An Vermeulen

5PUBLICATIONS
21CO-AUTHORS
Biomolecular modelling and designEpidemiological modellingGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 05, 2026
MBMA Bridging Models as a Tool for Exploration of Clinical Endpoints in Unstudied Indications.

|Nov 17, 2025
A Model-Based Meta-Analysis Framework Quantifying Drivers of Placebo Response in Atopic Dermatitis Trials.

Jean C Serrano, John Maringwa, Roel Straetemans

|Mar 24, 2024
Model-based meta-analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B-infected mice.

Louis Sandra, Huybrecht T'jollyn, An Vermeulen

|Mar 15, 2024
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions.

Jie Shao, Marion Vetter, An Vermeulen

|Jun 24, 2022
Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up data.

Pieter-Jan De Sutter, Maxime Van Haeverbeke, Eva Van Braeckel

Pageof 1

Frequent Collaborators

1 joint publications

Pieter-Jan De Sutter

1 joint publications

Maxime Van Haeverbeke

1 joint publications

Eva Van Braeckel

1 joint publications

Stephanie Van Biervliet